Overuse of short-acting beta-agonists (SABA) and risk factors among patients with asthma
H. Worth (Fürth, Germany), C. Criée (Göttingen, Germany), C. Vogelmeier (Marburg , Germany), P. Kardos (Frankfurt, Germany), E. Becker (Frankfurt, Germany), K. Kostev (Frankfurt, Germany), I. Mokros (Wedel, Germany), A. Schneider (Wedel, Germany)
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Worth (Fürth, Germany), C. Criée (Göttingen, Germany), C. Vogelmeier (Marburg , Germany), P. Kardos (Frankfurt, Germany), E. Becker (Frankfurt, Germany), K. Kostev (Frankfurt, Germany), I. Mokros (Wedel, Germany), A. Schneider (Wedel, Germany). Overuse of short-acting beta-agonists (SABA) and risk factors among patients with asthma. 2633
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: